Mass Vaccine and Drug Administration, Bangladesh
NCT06068530
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
10000
Enrollment
OTHER
Sponsor class
Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG:
DHA/piperaquine and a SLD-PQ
BIOLOGICAL:
Study vaccine R21/Matrix-M™
Sponsor
University of Oxford